MENU
+Compare
BRKRP
Stock ticker: NASDAQ
AS OF
Feb 2, 11:12 AM (EDT)
Price
$341.30
Change
-$5.55 (-1.60%)

BRKRP Bruker Corporation Forecast, Technical & Fundamental Analysis

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries... Show more

BRKRP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BRKRP with price predictions
Jan 30, 2026

BRKRP's Stochastic Oscillator is staying in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRKRP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (11.669). P/E Ratio (0.000) is within average values for comparable stocks, (38.773). BRKRP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.643). Dividend Yield (0.011) settles around the average of (0.018) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (38.054).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BRKRP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRKRP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
BRKRP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBFS14.150.16
+1.14%
Pioneer Bancorp
TBB22.460.04
+0.18%
AT&T
CLBK16.27-0.05
-0.31%
Columbia Financial
ABVC2.02-0.06
-2.88%
ABVC BioPharma
EGO42.92-5.24
-10.88%
Eldorado Gold Corp